NEW YORK--(BUSINESS WIRE)--ImClone Systems Incorporated (NASDAQ: IMCL), a leader in the development and commercialization of novel cancer therapeutics, today announced that the Company is scheduled to present at the Bear Stearns 20th Annual Healthcare Conference in New York, NY on Tuesday, September 11, 2007 at 9:00 a.m. EDT. A corporate overview will be provided, including a review of recent highlights.
